Skip to main content

Somatische Veränderungen im Alter

  • Chapter
  • First Online:

Zusammenfassung

Altern stellt einen komplexen, multifaktoriellen Prozess dar, der in Abhängigkeit vom jeweiligen Organsystem schon früh beginnen kann. So zeigen sich z. B. an der Niere schon ab dem 40. Lebensjahr Veränderungen der Organdurchblutung, die bereits als Beginn eines Alterungsprozesses gesehen werden. Die Alterungsvorgänge haben im Allgemeinen eine Abnahme der Funktionalität der Organsysteme zur Folge. Diese physiologischen altersassoziierten Rückbildungsprozesse führen nicht immer zu einer für den Betroffenen spürbaren Funktionsbeeinträchtigung, bewirken jedoch eine Einschränkung der Fähigkeiten von verschiedenen Homöostase-erhaltenden biologischen Prozessen.

Im Folgenden werden die altersbedingten Veränderungen einzelner Organsysteme kurz dargestellt. In ◘ Tab. 4.1 werden wichtige altersphysiologische Veränderungen verschiedener Organsysteme und die damit assoziierten Dysfunktionen und Erkrankungen zusammengefasst.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  1. Péquignot R, Belmin J, Chauvelier S et al (2009) Renal function in older hospital patients is more accurately estimated using the Cockcroft-Gault Formula than the Modification Diet in Renal Disease Formula. J Am Geriatrics Soc 57:1638–1643

    Article  Google Scholar 

  2. Bowker LK, Price JD, Smith SC (2006) Oxford Handbook of Geriatric Medicine

    Google Scholar 

  3. Sharma G, Goodwin J (2006) Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 1:253–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Clement FJ (1974) Longitudinal and cross-sectional assessments of age changes in physical strength as related to sex, social class and mental ability. J Gerontol 29:423–429

    Article  CAS  PubMed  Google Scholar 

  5. Frontera WR, Hughes VA, Lutz KJ, Evans WJ (1991) A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol 71:644–650

    CAS  PubMed  Google Scholar 

  6. Priemel M, Münch C, Beil FT et al (2006) Pathophysiologie und Pathomorphologie der Osteoporose. Radiologe 46(10):831–838

    Article  CAS  PubMed  Google Scholar 

  7. Verfassung der Weltgesundheitsorganisation.(1946) Absatz 2. New York

    Google Scholar 

  8. DVO-Leitlinie 2006 zur Prophylaxe und Therapie der Osteoporose; Dachverband Osteologie e. V.

    Google Scholar 

  9. Bröll H, Resch H, Pietschmann P et al (2007) Konsensus-Statement: Therapie der postmenopausalen Osteoporose – Anwendungsbereiche von parenteralen Bisphosphonaten. J Miner Stoffwechsel 14(1):45–48

    Google Scholar 

  10. Boonen S, Autier P et al (2004) Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int 15(2):87–94

    Article  PubMed  Google Scholar 

  11. Osnes EK, Lofthus CM et al (2004) Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int 15(7):567–574

    Article  CAS  PubMed  Google Scholar 

  12. Alegre-Lopez J, Cordero-Guevara J et al (2005) Factors associated with mortality and functional disability after hip fracture: an inception cohort study. Osteoporos Int 16(7):729–736 (Epub 2004 Oct 30)

    Article  PubMed  Google Scholar 

  13. Jiang HX, Majumdar SR et al (2005) Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 20(3):494–500 (Epub 2004 Nov 29)

    Article  CAS  PubMed  Google Scholar 

  14. Smektala R, Ohmann C et al (2005) On the prognosis of hip fractures: Assessment of mortality after hip fractures by analyzing longitudinal data from acute and rehabilitative care. Unfallchirurg. Jul 21; [Epub ahead of print]

    Google Scholar 

  15. DVO-Leitlinie 2009 zur Prophylaxe und Therapie der Osteoporose; Dachverband Osteologie e. V.

    Google Scholar 

  16. Mayer G, Köpke S, Mühlhauser I (2005) Effizienz pflegerischer Einschätzung im Vergleich zu empfohlenen Testinstrumenten zur Vorhersage des Sturzrisikos in Alten- und Pflegeheimen. Pflege und Gesellschaft 10(1)

    Google Scholar 

  17. Bischoff-Ferrari HA, Dawson-Hughes B et al (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sharma G, Goodwin J (2006) Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 1:253–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Cambier J (2006) Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev 205:5–6

    Article  Google Scholar 

  20. Agrawal A, Agrawal S, Cao JN et al (2007) Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 178:6912–6922

    Article  CAS  PubMed  Google Scholar 

  21. Arnold CR, Wolf J, Brunner S et al (2011) Gain and loss of T cell subsets in old age-age-related reshaping of the T cell repertoire. J Clin Immunol 31:137–146

    Article  PubMed  Google Scholar 

  22. Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141–155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Derhovanessian E, Larbi A, Pawelec G (2009) Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 21:440–445

    Article  CAS  PubMed  Google Scholar 

  24. Derhovanessian E, Maier AB, Beck R et al (2010) Hallmark features of immunosenescence are absent in familial longevity. J Immunol 185:4618–4624

    Article  CAS  PubMed  Google Scholar 

  25. Effros RB (2011) Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol 46:135–140

    Article  CAS  PubMed  Google Scholar 

  26. Grubeck-Loebenstein B, Della Bella S, Iorio AM et al (2009) Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 21:201–209

    Article  CAS  PubMed  Google Scholar 

  27. Jylhava J, Eklund C, Jylha M et al (2011) Expression profiling of immune-associated genes in peripheral blood mononuclear cells reveals baseline differences in co-stimulatory signalling between nonagenarians and younger controls: the vitality 90+ study. Biogerontology 11:671–677

    Article  Google Scholar 

  28. Lang PO, Govind S, Michel JP et al (2011) Immunosenescence: implications for vaccination programmes in adults. Maturitas 68:322–330

    Article  PubMed  Google Scholar 

  29. Medzhitov R (2010) Inflammation 2010: new adventures of an old flame. Cell 140:771–776

    Article  CAS  PubMed  Google Scholar 

  30. Pawelec G (2006) Immunity and ageing in man. Exp Gerontol 41:1239–1242

    Article  CAS  PubMed  Google Scholar 

  31. Sansoni P, Vescovini R, Fagnoni F et al (2008) The immune system in extreme longevity. Exp Gerontol 43:61–65

    Article  CAS  PubMed  Google Scholar 

  32. Strindhall J, Nilsson BO, Lofgren S et al (2007) No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 42:753–761

    Article  CAS  PubMed  Google Scholar 

  33. Wenisch C, Patruta S, Daxbock F et al (2000) Effect of age on human neutrophil function. J Leukoc Biol 67:40–45

    CAS  PubMed  Google Scholar 

  34. Wikby A, Johansson B, Olsson J et al (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445–453

    Article  CAS  PubMed  Google Scholar 

  35. Peters T (2011) Immunseneszenz. Hautarzt 62:598–606

    Article  CAS  PubMed  Google Scholar 

  36. Mangoni A, Jackson H (2003) Age-related changesin pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Pharmacol 57:6–14

    Article  Google Scholar 

  37. Hubbard R, O’Mahoney M et al (2012) Medication prescribing in frail older people. Eur J Clin Pharmacol : doi:10.1007/s00228-012-1387-2

    Google Scholar 

  38. Harman D (1998) Aging: phenomena and theories. Ann N Y Acad Sci 854:1–7

    Article  CAS  PubMed  Google Scholar 

  39. McLachlan MS (1978) The ageing kidney. Lancet ii:143–145

    Article  Google Scholar 

  40. Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278–285

    Article  CAS  PubMed  Google Scholar 

  41. Meyer BR (1989) Renal function in aging. J Am Geriatr Soc 37:791–800

    Article  CAS  PubMed  Google Scholar 

  42. Phillips PA, Rolls BJ, Ledingham JG et al (1984) Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 311:753–759

    Article  CAS  PubMed  Google Scholar 

  43. O’Neill PA, McLean KA (1992) Water homeostasis and ageing. Med Lab Sci 49:291–298

    PubMed  Google Scholar 

  44. Blechman MB, Gelb AM (1999) Aging and gastrointestinal physiology. Clin Geriatr Med 15:429–438

    CAS  PubMed  Google Scholar 

  45. Husebye E, Engedal K (1992) The patterns of motility are maintained in the human small intestine throughout the process of aging. Scand J Gastroenterol 27:397–404

    Article  CAS  PubMed  Google Scholar 

  46. Madsen JL (1992) Effects of gender, age, and body mass index on gastrointestinal transit times. Dig Dis Sci 37:1548–1553

    Article  CAS  PubMed  Google Scholar 

  47. Graff J, Brinch K, Madsen JL (2001) Gastrointestinal mean transit time in young and middle-aged healthy subjects. Clin Physiol 21:253–259

    Article  CAS  PubMed  Google Scholar 

  48. Schmucker DL (2001) Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 18:837–851

    Article  CAS  PubMed  Google Scholar 

  49. Hunt CM, Westerkam WR, Stave GM (1992) Effect of age and gender on the activity of human hepatic CYP3 A. Biochem Pharmacol 44:275–283

    Article  CAS  PubMed  Google Scholar 

  50. Yuan R, Venitz J (2000) Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs. Int J Clin Pharmacol Ther 38:245–253

    Article  CAS  PubMed  Google Scholar 

  51. Pichette V, Leblond FA (2003) Drug metabolism in chronic renal failure. Curr Drug Metab 4:91–103

    Article  CAS  PubMed  Google Scholar 

  52. Rostami-Hodjegan A, Kroemer HK, Tucker GT (1999) In vivo indices of enzyme activity. the effect of renal impairment on the assessment of CYP2D6 activity. Pharmacogenetics 9:277–286

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Wien

About this chapter

Cite this chapter

Langsenlehner, U., Muchar, H., Schippinger, W. (2013). Somatische Veränderungen im Alter. In: Pinter, G., Likar, R., Schippinger, W., Janig, H., Kada, O., Cernic, K. (eds) Geriatrische Notfallversorgung. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1581-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1581-7_4

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1580-0

  • Online ISBN: 978-3-7091-1581-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics